Pan-cancer analyses reveal the prognostic and immune relevance of OAS1 and its pro- migratory role in cervical cancer
This study identifies OAS1 as a pan-cancer prognostic and immune biomarker that is upregulated in cervical cancer, where it drives malignant migration and invasion by increasing reactive oxygen species levels, highlighting its potential as a therapeutic target.